Anti-TNF therapy using etanercept suppresses degenerative and inflammatory changes in skeletal muscle of older SJL/J mice (Q83418518)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Anti-TNF therapy using etanercept suppresses degenerative and inflammatory changes in skeletal muscle of older SJL/J mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Hiroshi Nemoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Shingo Konno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Hideki Sugimoto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Hiroshi Nakazora

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Nobuatsu Nomoto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Mayumi Murata

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Hisao Kitazono

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Toshiki Fujioka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

12 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

Experimental and Molecular Pathology

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

264-270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

Defective membrane repair in dysferlin-deficient muscular dystrophy

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Mast cells play a pivotal role in ischaemia reperfusion injury to skeletal muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Administration of the non-steroidal anti-inflammatory drug ibuprofen increases macrophage concentrations but reduces necrosis during modified muscle use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

The role of tumor necrosis factor-alpha (TNF-alpha) in skeletal muscle regeneration. Studies in TNF-alpha(-/-) and TNF-alpha(-/-)/LT-alpha(-/-) mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Repairing the tears: dysferlin in muscle membrane repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Muscle pathology in dysferlin deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Molecular treatments in Duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Caveolin regulates endocytosis of the muscle repair protein, dysferlin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Conservation of the Duchenne muscular dystrophy gene in mice and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Up-regulation of MHC class I expression accompanies but is not required for spontaneous myopathy in dysferlin-deficient SJL/J mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Dysferlin Interacts with Annexins A1 and A2 and Mediates Sarcolemmal Wound-healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Properties of reticulum-cell sarcomas in SJL/J mice. I. Proliferative response to tumor cells of T-derived lymphoid cells from normal mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Anti-TNF Treatment Reverts Increased Muscle Ubiquitin Gene Expression in Tumour-Bearing Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Experimental allergic myositis in SJL/J mice immunized with rabbit myosin B fraction: immunohistochemical analysis and transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

FK506 suppressed the inflammatory change of EAM in SJL/J mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Histological and immunohistological changes of the skeletal muscles in older SJL/J mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Interactions between neutrophils and macrophages promote macrophage killing of rat muscle cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Tumour necrosis factor inhibitors: risks and benefits in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Multifaceted roles of TNF-? in myoblast destruction: A multitude of signal transduction pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Inflammatory processes in muscle injury and repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Cloning of the mouse dysferlin gene and genomic characterization of the SJL-Dysf mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Physiological role of tumor necrosis factor alpha in traumatic muscle injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

Spontaneous myopathy in the SJL/J mouse: pathology and strength loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.02.003

10.1016/J.YEXMP.2011.02.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21324312%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference